Yan Yin

3PUBLICATIONS

45CO-AUTHORS

Molecular targetsHaematological tumoursBiomolecular modelling and design

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Nov 16, 2023

First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors.

Nehal J Lakhani, Drew Rasco, Hengbang Wang

|Oct 14, 2022

Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies.

Yifan Zhai, Qiuqiong Tang, Douglas D Fang

|Sep 01, 2022

Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy.

Jing Deng, Aneel Paulus, Douglas D Fang

Pageof 1

Frequent Collaborators

3 joint publications

Yifan Zhai

3 joint publications

Dajun Yang

2 joint publications

Jing Deng

2 joint publications

Douglas D Fang

2 joint publications

Hengbang Wang

2 joint publications

Ping Min

1 joint publications

Aneel Paulus

1 joint publications

Matthew S Davids

1 joint publications

Guangfeng Wang

1 joint publications

Saijie Zhu

Frequent Collaborators

3 joint publications

Yifan Zhai

3 joint publications

Dajun Yang

2 joint publications

Jing Deng

2 joint publications

Douglas D Fang